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Acute study of interaction among cadmium, calcium, and zinc transport along the rat nephron in vivo , and Zn 2ϩ in the proximal tubule (PT), loop of Henle (LH), and terminal segments of the nephron (DT) using whole kidney clearance and nephron microinjection techniques. Acute Cd 2ϩ injection resulted in renal losses of Na ϩ , K ϩ , Ca 2ϩ , Mg 2ϩ , PO 4 Ϫ2 , and water, but the glomerular filtration rate remained stable. 45 Ca microinjections showed that Ca 2ϩ permeability in the DT was strongly inhibited by Cd 2ϩ (20 M) , Gd 3ϩ (100 M), and La 3ϩ (1 mM), whereas nifedipine (20 M) had no effect. 109 Cd and 65 Zn 2ϩ microinjections showed that each segment of nephron was permeable to these metals. In the PT, 95% of injected amounts of 109 Cd were taken up. 109 Cd fluxes were inhibited by Gd 3ϩ (90 M), Co 2ϩ (100 M), and Fe 2ϩ (100 M) in all nephron segments. Bumetanide (50 M) only inhibited 109 Cd fluxes in LH; Zn 2ϩ (50 and 500 M) inhibited transport of 109 Cd in DT. In conclusion, these results indicate that 1) the renal effects of acute Cd 2ϩ intoxication are suggestive of proximal tubulopathy; 2) Cd 2ϩ inhibits Ca 2ϩ reabsorption possibly through the epithelial Ca 2ϩ channel in the DT, and this blockade could account for the hypercalciuria associated with Cd 2ϩ intoxication; 3) the PT is the major site of Cd 2ϩ reabsorption; 4) the paracellular pathway and DMT1 could be involved in Cd 2ϩ reabsorption along the LH; 5) DMT1 may be one of the major transporters of Cd 2ϩ in the DT; and 6) Zn 2ϩ is taken up along each part of the nephron and its transport in the terminal segments could occur via DMT1. heavy metals; epithelial calcium channel; divalent metal transporter 1; kidney CADMIUM (CD 2ϩ ) IS ONE OF THE most commonly found toxic metals present in our environment. The major sources of exposure to Cd 2ϩ are contaminated food and water, tobacco, and industrial fumes and dusts (16) . Cd 2ϩ accumulates in the body, and chronic exposure causes severe nephrotoxicity in humans (16) and animals (2, 4) . The renal dysfunction may be due to proximal tubular damage affecting the passive paracellular pathway (14, 27) and decreasing active transcellular ion transport (30) . With the use of in vitro models, deleterious effects of Cd 2ϩ have been described on several solute transporters, such as stretch-activated ion channels (24) , the epithelial Ca 2ϩ channel (ECaC) transporter (32) , the NaPi-II transporter (19) , the Na/glucose transporter (1) , and the NaSi-1 transporter (25) . These acute effects of Cd 2ϩ suggest the involvement of ion transporters in Cd 2ϩ -induced nephropathy. Therefore, the question arises as to whether these transporters are affected in vivo after Cd 2ϩ exposure. To answer this question, studies have been performed in animal models chronically intoxicated with Cd 2ϩ (22, 31) . Unfortunately, severe intoxication induces renal solute wasting, as well as nephrotoxic damage to glomeruli and proximal tubular structures, which could mask more subtle alterations in transporter function.
It has been clearly demonstrated that free cytosolic Cd 2ϩ is responsible for the toxicological damage to cells and that the bound form of Cd, complexed with proteins like albumin and metallothionein, plays a protective role (8) . Cd 2ϩ increases urine Ca 2ϩ excretion (28) , which can affect bone metabolism and cause severe bone pathology (29) . A blockade of the distal Ca 2ϩ transporter (ECaC) was proposed to explain Cd 2ϩ -induced hypercalciuria and associated renal stone formation (26) . In light of these findings, it is evident that Cd 2ϩ may interact with several different transporters. Such interactions suggest the participation of pathways for free Cd 2ϩ reabsorption. Therefore, the free ionized Cd 2ϩ might be, with CdMT, Cd-GSH, and Cys-Cd, one of the reabsorbed forms of Cd. Although the uptake of free Cd 2ϩ accounts for a minor portion of cellular Cd 2ϩ uptake in vivo, it could be of interest to identify the transporters involved because the Cd 2ϩ complexed to small peptides may be released at the brush border and then taken up as a free ion by renal cells (27) . For this purpose, we have chosen to use acute perfusion of Cd 2ϩ and microinjections of 109 Cd to study the renal handling of Cd. These protocols minimized the participation of bound Cd forms in Cd reabsorption because the de novo metallothionein or glutathione synthesis induced by Cd 2ϩ takes several hours and very little Cd 2ϩ -albumin complexes are present in the tubular fluid. Initial data were reported by Felley-Bosco and Diezi (9) . Using in vivo micropuncture and microinjection techniques in the rat, these authors showed that Cd 2ϩ was mainly reabsorbed in the proximal tubule and that a sodium-cysteine cotransporter was involved. Since their study, a divalent metal transporter (DMT1) has been cloned (18) and immunolocalized to the apical membrane of the thick ascending limb (TAL), distal tubule (DT), and the cortical collecting tubule (CCT) of the rat nephron (11), suggesting a role for this transporter in the renal handling of divalent metal cations. In a recent study, Wareing et al. (34) (18) . In view of these findings, we decided to re-investigate Cd 2ϩ transport along the rat nephron and its relationship to other cations.
MATERIALS AND METHODS
Three types of experimental techniques were used: clearance, tracer microinjection, and micropuncture. The experiments were carried out in female Wistar rats weighing 180 -220 g. The animals were fed a standard laboratory diet. They had free access to water until the start of the experiment and were starved for 18 h before the surgical procedure. Anesthesia was induced by injection of pentobarbital sodium (Nembutal, 5 mg/100 g body wt ip) and maintained by additional 1-mg doses administered when necessary. The animals were then placed on a heated table to maintain their body temperature between 37 and 39°C. A tracheotomy was performed leaving the thyroid gland untouched. One catheter (PE-20) was inserted into the right jugular vein for perfusion of experimental solutions and another (PE-10) into the left ureter for urine collection. For clearance experiments, a third catheter (PE-50) was inserted into the right femoral artery for blood sampling and arterial blood pressure recording (Research BP Transducer, Harvard Apparatus). For tracer microinjection experiments, the kidney was ventrally exposed as described by Gottschalk and Mylle (14) . The use of animals was in accordance with the ILAR Guide for Care and Use of Laboratory Animals.
Clearance Experiments
These experiments were performed to analyze the effect of an acute load of Cd 2ϩ on whole kidney function. Because it is necessary to induce diuresis when microinjection techniques are used, it was important to determine the effect of Cd 2ϩ under the chosen diuretic conditions. Therefore, clearance experiments were carried out in rats intravenously (iv) infused with a 2% NaCl solution at a rate of 100 l/min. [ 3 H]metoxy-inulin (0.53 Ci/mmol) was used to measure the glomerular filtration rate (GFR). Urine samples were collected serially every 10 min, and blood samples were taken halfway through each urine collection. In all experiments a loading dose of [ 3 H]inulin (4 Ci) was given iv, followed by a continuous infusion of 0.4 Ci/min for the duration of each experiment. Urine collection began 1 h after the administration of the [ 3 H]inulin priming dose. After three control clearance periods, Cd 2ϩ was added and infused continuously at a rate of 880 M/min to maintain a plasma concentration of ϳ5 M. After a 40-min equilibration period, urine was collected during three additional 10-min clearance periods.
Tracer Microinjections
Droplets of isotonic buffered solutions containing traces of [ 3 H]inulin and the radioactive isotope of the divalent metal ion under investigation were prepared for injection into early proximal, late proximal, early distal, or late DT sites. The volume injected was 3 nl, and the duration of the injection ranged between 20 and 90 s. The method used to identify the structure was identical to that reported previously (21) . Briefly, the tubule segment was selected from its shape, location, and refringence and identified by injecting a small volume (ϳ2 nl of isotonic NaCl solution colored with 0.05% of erioglaucine dye) just before the microinjection. At the start of each microinjection, four 60-s, three 1-min, and two 2-min urine samples were collected serially directly into counting vials containing 2 ml of scintillant. This was followed by a 2-min urine collection to determine the urine flow rate. The amount of injected radioactivity was measured by counting the radioactivity of the injected droplet. Background in the urine was calculated from the activity of the urine samples collected just before each microinjection. Urine recovery for each tracer was expressed as a percentage of the amount injected. This amount in the urine reflects reabsorption of the tracer in all downstream segments.
Control of Injection Site
To ensure that the chosen microinjection site was reproducible from one tubule to another, we have performed parallel micropuncture experiments to measure the F/P inulin at the injection site. Diuretic rats were continuously infused with [ 3 H]inulin (3 Ci/min), and, after a 1-h equilibration period, tubular fluid was collected for 1-2 min in proximal and distal tubules identified as described above.
Late Proximal Micropunctures
The protocol of [ 3 H]inulin infusion and the method used to identified the structure were the same as that for the microinjection technique. Late proximal tubular fluid samples were collected. under free-flow conditions. Each collection lasted 60 -120 s. Three successive 30-min clearance periods were performed to determine [ 3 H]inulin and Cd 2ϩ concentrations in urine and plasma. Ultrafiltrable plasma Cd 2ϩ concentration was estimated by measuring Cd 2ϩ after the plasma was spun through a 30-kDa filter (Centrifree micropartition system; Amicon).
Analytic Procedure
3 H, 109 Cd, 45 Ca, and 65 Zn radioactivities were measured by liquid scintillation counting (Packard). In plasma and urine samples, Na ϩ , K ϩ , Mg 2ϩ , Ca 2ϩ , Cl Ϫ , and Pi concentrations were determined by ion exchange chromatography (AS50/BioLC, Dionex), and Cd 2ϩ was measured by atomic absorption spectrometry using a Zeeman furnace system (Solaar 969, Thermo Optek).
Student's t-test was used for statistical analysis. The data are expressed as means Ϯ SE. P Ͻ 0.05 was considered significant.
Radioactive Material
All radioactive elements were produced by Amersham Pharmacia Biotech UK: [ 3 H]inulin (TRA324), specific radioactivity 120 Ci/mg inulin; calcium-45 (CES.3), specific radioactivity 5-50 mCi/mg 45 Ca; cadmium-109 (CUS.1), specific radioactivity 50 -1,000 Ci/g 109 Cd; and zinc-65 (ZAS.2), specific radioactivity 83 Ci/mg 65 Zn.
RESULTS

Clearance Experiments
The effect of an acute load of Cd 2ϩ on whole kidney function was assessed using the clearance technique. Arterial blood pressure was similar during the control and Cd 2ϩ infusions (126.2 Ϯ 0.5 and 128.5 Ϯ 4.4 mmHg, respectively; P Ͼ 0.05, n ϭ 8). Sham-treated animals did not show any significant changes over time in plasma Na
Ϫ2 concentrations, whereas plasma Mg 2ϩ concentration decreased slightly during the saline infusion ( Fig. 1) . Concomitantly, urine flow rate, GFR, and electrolyte fractional excretion (FE) remained stable (Fig. 2) . In experimental animals, the infusion of Cd 2ϩ increased plasma Cd 2ϩ concentration to 3.03 Ϯ 0.32 M and was associated with a significant fall in plasma Ca 2ϩ , Mg 2ϩ , K ϩ , Na ϩ , and PO 4 Ϫ2 concentrations (Fig.  1) ; although urine flow rate increased and GFR was unchanged (Fig. 2) (Fig. 2) ; most of the filtered Cd 2ϩ was reabsorbed by the kidney (FE ϭ 0.0018 Ϯ 0.0005%, n ϭ 15).
Tracer Microinjection Experiments
First, as shown in Fig. 3A , there was a correlation between the F/P inulin values and the injection site, indicating that the morphological criteria used to estimate the injection site did (Table 1;  see Tables 3 and 4 ). In a separate series (n ϭ 3, Fig. 3B ), we evaluated nonspecific binding of the tracer to plasma membranes. No change in urine recovery of radioactivity from background occurred after the perfusion of a high concentration of the nonradioactive ion after 109 concentration of the injected solution was 4.5 M. In this experimental series, the Ca 2ϩ injection rate ranged between 1 and 3 pmol/min, indicating that Ca 2ϩ was introduced into the tubular lumen at tracer doses, because from free-flow micropuncture studies it can be calculated that the mean flow rate of Ca 2ϩ varies from 80 pmol/min at the beginning of the proximal tubule to 15 pmol/min at the end of the DT in rats (30) . In our experiments, the total amount of Ca 2ϩ injected did not significantly increase the normal free-flow delivery rate of Ca 2ϩ to the segment located downstream of the injection site, because no significant correlation between the injection rate and the 45 Ca recoveries has been found and the cumulative curves of [ 3 H]inulin and 45 Ca excretions show that both isotopes appeared in urine and reached their maximum excretion in parallel (data not shown). Table 1 shows that recovery of 45 Ca, expressed as a percentage of 45 Ca microinjected, depended on the injection site: the more proximal the injection, the lower the 45 Ca urine recovery. The differences between the 45 Ca recovery at each microinjection site allow an estimate of the unidirectional 45 Ca fluxes (expressed as percent delivered load) and provide a measure of Ca 2ϩ reabsorption occurring between the early and late proximal tubules, the late proximal and early DTs (including the LH), the early and late DT [corresponding to the distal convoluted tubule (DCT)], and the late DT and final urine [including the connecting tubule (CNT) and the convoluted tubule (CT)]. This mode of calculation is valid for calcium because injected 45 Ca was in a tracer-dose condition and because a sufficient load of filtered Ca 2ϩ was delivered to each segment downstream of the proximal tubule. Under control conditions, Ͼ65% of the injected Ca 2ϩ was reabsorbed between the late proximal and the early DT, whereas Ͼ20% was reabsorbed between the early and late DTs (Tables 1 and 2 ). The addition of Cd 2ϩ (20 M), Gd 3ϩ (100 M), or La 3ϩ (1 mM) significantly increased 45 Ca urine recovery when microinjections were performed at the early proximal tubule site (Table1). This increase was mainly due to a decrease in unidirectional 45 Ca flux between the early and Fig. 2 . Effects of 5 M Cd 2ϩ infusion on glomerular filtration (expressed in ml/min), U/P inulin, urine flow rate (expressed in l/min), and fractionnal excretions (FE) of Ca 2ϩ , Mg 2ϩ , Na ϩ , K ϩ , Cl Ϫ , and PO 4 Ϫ2 (expressed %) in Wistar rats during mild diuretic conditions. F, Control rats (n ϭ 5); E, experimental rats (n ϭ 5) exposed to Cd 2ϩ throughout the 30-min period. Time 0 corresponds to the start of the first urine collection period after 1 h of equilibration. Values are means Ϯ SE calculated for each clearance period, refer to the difference in the change in glomerular filtration rate (GFR), U/P inulin, urine flow rate, and fractional excretions between periods without and with Cd 2ϩ by Student's t-test (*P Ͻ 0.05, **P Ͻ 0.001).
late distal segments (Table 2 ). In contrast, nifedipine did not modify 45 Ca recovery at each injection site (Tables 1 and 2 ). The percent inhibition of distal 45 Ca reabsorption produced by each agent used is shown in Fig. 4 .
109 Cd. The same concentration of Cd 2ϩ (5 M) was used as for a clearance study. This concentration corresponded to that determined during mild chronic exposure (36, 38). The absence of a significant correlation between the Cd 2ϩ injection rates and urine recovery (data not shown) has been verified, indicating that under these conditions, the percentage of urine 109 Cd were roughly parallel (data not shown) at the three injection sites. Table 3 shows that the urine 109 Cd recovery after early proximal microinjection was close to 5% of the amount injected, indicating an important transport of Cd 2ϩ in segments beyond this site. The 109 Cd excretion was greater when the injections were performed in late proximal and early DTs. Using Cd 2ϩ concentrations ranging between 0.005 and 50 mM, microinjections indicate saturation at high Cd 2ϩ concentrations in each segment (Fig. 5) . These results showed that the segment between early and late proximal sites exhibited an important reabsorptive capacity for Cd 2ϩ because in the presence of 50 mM Cd 2ϩ , 45% of Cd is reabsorbed. In contrast, the DT exhibited a lower reabsorptive capacity because 5 mM Cd 2ϩ is sufficient to saturate the uptake in this segment. To characterize further the transport mechanisms involved in 109 Cd fluxes, microinjections were performed in the presence of different cations (Table 3) . Unfortunately, in contrast to calcium, the difference between the 109 Cd recovery at each microinjection site could not be used to estimate the unidirectional 109 Cd in each segment of the nephron flux. This is due to the fact that 109 Cd microinjections were not performed in the tracer-dose condition (an endogenous pool of Cd 2ϩ does not exist) and because most of Cd 2ϩ was taken up by the proximal tubule (see micropuncture results below) so that the amount of 109 Cd delivered to the downstream segments after early proximal microinjection was too low to allow mathematical calculation performed for calcium. Therefore, the results were interpreted on the basis of 109 Cd urinary recovery after microinjection in early proximal, late proximal, and early DT, respectively. In early, late proximal, and early distal microinjections, the addition of Gd 3ϩ (90 M), Co 2ϩ (100 M), or Fe 2ϩ (100 M) induced a strong increase in 109 Cd urine excretion. These data are consistent with a decrease in unidirectional 109 Cd fluxes in proximal tubule, LH, and terminal nephron segments ( Table 3 ). The effect of Zn 2ϩ is more complicated, because it clearly depends on the concentration used: at a low concentration (50 M), the addition of Zn 2ϩ increased 109 Cd excretion only in early distal injections; at a high concentration (500 M), Zn 2ϩ enhanced 109 Cd excretion at every injected site. The diuretic bumetanide had an effect only at late proximal sites, suggesting that blockade of the Na ϩ -K ϩ -2Cl Ϫ transporter in the LH induces a decrease in 109 Cd transport in this segment (Table 3) . 65 Zn. As for 45 Ca and 109 Cd, 65 Zn microinjections were performed in early, late proximal, and early DTs. With the specific radioactivity of 65 Zn available commercially, the minimal concentration in the microinjected solution ranged between 17 and 34 M, which is higher than the plasma free Zn 2ϩ concentration (15 M). The absence of a positive correlation between the injection rate and 65 Zn urine recovery satisfies tracer-dose requirements (data not shown). As shown in Table 4 , 65 Zn urine excretion increased from early proximal to early distal microinjection sites, indicating significant Zn 2ϩ reabsorption along the proximal tubule, LH, and terminal nephron segments. 65 Zn microinjections performed in the presence of 50 M Cd 2ϩ showed a slight inhibitory effect of Cd 2ϩ on zinc transport along the early proximal tubule and the LH (Table 4) . These results also indicate an important inhition of 65 Zn transport along the terminal segments of the nephron.
Cd Micropuncture Experiments
Micropuncture experiments were performed to investigate the amount of Cd delivered to the late proximal tubule during an acute Cd loading. To be consistent with clearance and microinjection experiments, total plasma concentration of Cd 2ϩ was maintained at 5 M throughout the experiments. Under these conditions, the estimated ultrafiltrable plasma Cd concentration was 2.8 Ϯ 0.2 M (n ϭ 7). Flow rate and single-nephron glomerular filtration were 34 Ϯ 9 and 38 Ϯ 4 nl/min (n ϭ 7), respectively. The fractional delivery of Cd at the end of the accessible proximal tubule was 14.6 Ϯ 1.4% (n ϭ 7). Thus most of the 85% of the filtered Cd 2ϩ was reabsorbed between the glomerulus and the late proximal tubule.
DISCUSSION
The aim of this study was to investigate specifically the transport of free Cd 2ϩ in each segment of the nephron and to identify the putative transporters involved in the renal transport of Cd 2ϩ . First, it was important to check the effect of acute ]inulin into early proximal, late proximal, early distal, and late distal tubules of Wistar rats were performed in control condition (10 rats) and in the presence of Gd 3ϩ (4 rats), La 3ϩ (4 rats), Cd 2ϩ (7 rats), and nifedipine (3 rats). Early proximal data represent the percentage of excreted 45 Ca after microinjections in early proximal tubules, which reflect 45 Ca reabsorption in all the downstream segments after early proximal (proximal tubule, loop of Henle, distal tubule, and terminal segments). Late proximal data resulting from late proximal microinjections reflect 45 Ca reabsorption in all the downstream segments after late proximal (loop of Henle, distal tubule, and terminal segments). Early distal data reflect 45 Ca reabsorption along distal and terminal segments, and late distal data reflect 45 Ca reabsorption along terminal segments. 45 Ca reabsorption in proximal convoluted tubule (PCT). CNT, connecting tubule; CCT, cortical convoluted tubule. 45 Ca reabsorption in the loop is obtained by difference between 45 Ca recovery after early distal and late proximal injections. Results are expressed as percentage of delivered load. the proximal tubule (30) , this is the first study to show that acute injection of Cd 2ϩ can produce a Fanconi-like pattern of ion excretion. In the TAL segment of the LH, Cd 2ϩ could reduce reabsorption by blocking ROMK channels (22) . An effect on K ϩ recycling in the apical membrane might account for reduced Na ϩ and K ϩ reabsorption, as well a decrease in paracellular transport of divalent cations. A dysfunction of the terminal segments of the nephron could also be involved in Cd 2ϩ -induced salt wasting. In the DT, Ca 2ϩ transport occurs via a transcellular pathway (3 Cd urinary recovery after late and early proximal microinjection did not reflect the 109 Cd transport between these two sites. The urinary recovery after early proximal microinjection probably corresponds to a best estimate of proximal transport. Finally, the present results indicated that 95% of Cd 2ϩ was taken up by the (17) and has been localized to the proximal S3 segment, the LH, the DCT, and collecting ducts (10) . In the proximal tubule, DMT1 is probably present in the endosomal compartment (10) , Cd 2ϩ is transported, at least in part, by DMT1 in the apical membrane of the LH, in its TAL segment where DMT1 has been shown to be present (10) .
In the LH and terminal nephron segments, 109 Cd microinjections in the presence of bumetanide highlight the role of a different pathway from the transcellular route for Cd 2ϩ transport. In the TAL, the paracellular pathway plays an important role in divalent cation reabsorption. Bumetanide, by inhibiting Na . In light of more recent experiments, it is likely that this membrane transporter is DMT1 (11) . Our data also support this conclusion, because distal Cd 2ϩ permeability was strongly blocked by Fe As far as zinc transport is concerned, the present study shows that Zn 2ϩ is transported along the proximal tubule, the LH, and the terminal segments of the nephron. The finding that a low Zn 2ϩ concentration (50 M) did not modify Cd 2ϩ transport in the proximal tubule and LH strongly suggests that Zn 2ϩ and Cd 2ϩ do not share the same uptake pathways in these segments. In the proximal tubule, Zn 2ϩ could be transported in the apical membrane as a free ion via a saturable carriermediated process and an unsaturable pathway, or complexed with histidine or cysteine via a sodium-amino acid cotransport mechanism (12) ; however, the interaction of Cd 2ϩ with such processes is unclear. In the LH, the lack of competition between Zn and Cd is perhaps surprising, because DMT1 has a strong affinity for Zn 2ϩ (17) and may be one of the Cd (19) . Thus the difference between the effects of Zn 2ϩ action on Cd 2ϩ uptake in the LH and more distal segments could be due to the pattern of expression of these different isoforms (33) .
The results obtained in the present study suggest several ways in which Cd 2ϩ might be eliminated: 1) in the proximal tubule by blocking paracellular and transcellular pathways (unknown for the moment); 2) in the LH by use of loop diuretics (such as bumetanide and furosemide) and DMT1 inhibition; and 3) in the distal tubule by DMT1 inhibition. Our findings on Cd 2ϩ transport highlight the need to characterize the properties in vivo of these different transport pathways and to develop pharmacological tools with which to manipulate DMT1 function.
